Protocol Name: Observational Study of Safety and Effectiveness of Elfabrio in Fabry Patients
Protocol #: CLI-06657AA1-10 (MODERN)
Indication: Fabry Disease
GFR: n/a
Principal Investigator: Ankit N. Mehta, MD, FASN
Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204